Pharmaceuticals

Pfizer, Ranbaxy Lipitor Generic Anticompetitive Agreement Class Action

With the high prices of US drugs, a popular medicine can be an enormous moneymaker for a pharmaceutical company. But the patents that give those companies exclusivity have a limited term, after which generics or bioequivalents can come on the market, driving prices downwards. The complaint for this antitrust class action alleges that a number  Read more

Premarin, Prempro, Premphase California Settlement

Wyeth, Inc. and Wyeth Pharmaceuticals, Inc. is settling a class action against it with a $200 million payment. The complaint alleged that Wyeth violated California laws by making false or misleading representations about the drugs Premarin, Prempro, and Premphase, including (a) that the medications lowered cardiovascular, Alzheimer’s, and dementia risks, and (b) that the medications  Read more

Analog Insulin Drug Makers’ Kickbacks to PBMs RICO Class Action

This class action alleges that pharmacy benefit managers (PBMs) are taking kickbacks from drug manufacturers in ways that raise the prices of prescription drugs. The drugs at issue in this case are analog insulin drugs, and the case has been brought by a drug wholesaler, which claims that it must pay more for drugs because  Read more

Loestrin 24 Fe, Minastrin 24 Fe Antitrust Settlement

This antitrust case has a long list of defendants, including companies related to Lupin, Warner Chilcott, and Watson. The complaint was filed by a group of end-payors who claimed that the companies violated antitrust laws and engaged in anticompetitive behavior by conspiring to keep generic versions of Loestrin 24 Fe and Minastrin 24 Fe off  Read more

Purdue Bankruptcy and Filing of Opioid-Related Claims

This is for those seeking compensation Purdue Pharma, LP, claiming harm from its actions or its opioids, such as OxyContin. Cases have been filed against Purdie and related companies, alleging that Purdue pushed its opioids excessively and deliberately underestimated their risks. Individuals are making claims for addiction and wrongful death, and even states have claimed  Read more

Gilead and Others HIV Drug Anticompetitive Agreements Class Action

Anticompetitive efforts in the field of pharmaceuticals have become more sophisticated in recent years. This antitrust class action concerns combination antiretroviral therapy (cART) regimen drugs used by patients with human immunodeficiency virus (HIV), a condition that can lead to Acquired Immunodeficiency Syndrome (AIDS) and death. The complaint alleges that a number of companies have conspired  Read more

Lovenox/Enoxaparin Antitrust Settlement

Momenta Pharmaceuticals, Inc. and Sandoz, Inc. are settling an antitrust class action alleging that they conspired to keep the prices of Lovenox and its generic enoxaparin higher than they should have been by manipulating the generic approvals process. While Momenta did not create the drug, the complaint says the companies manipulated the process to bring  Read more

Avandia Use and Cardiovascular Injuries Settlement

GlaxoSmithKline, Inc. and GlaxoSmithKline, LLC are settling a class action centering on their drug Avandia. The complaint alleged that people who took Avandia suffered heart attacks or congestive heart failure or needed coronary artery bypass grafts or percutaneous coronary intervention.  Read more

Infants’ Tylenol Settlement

Johnson & Johnson Consumer, Inc. offers an Infants’ Tylenol product that purportedly differs from its Children’s Tylenol. However, it is agreeing to settle a class action taking issue with the representations on the Infants’ Tylenol packaging. The complaint alleged that the designation “Infants’” and the representation of a mother holding a baby misleads consumers into  Read more

Sanofi-Aventis Zantac/Generics Produce NDMA in the Body Class Action

Zantac is a brand-name form of ranitidine, a stomach-acid reduction drug. The complaint for this class action alleges that certain companies involved in the making or marketing of Zantac—Sanofi-Aventis US, LLC, Sanofi US Services, Inc., Chattem, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., and GlaxoSmithKline, LLC (GSK)—have been continuing to put out the drug despite knowing that  Read more